MYRIAD GENETICS, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
MYRIAD GENETICS, INC. (MYGN) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $0 as of 2024-12-31, per its 10-K filed 2025-02-28.
Financial Statements › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2025-02-28
- 2024-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2024-09-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2024-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $0.00.
- 2024-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $5.40M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-02-28 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-07 |
| 2024-03-31 | $5.40M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $5.40M 10-K · filed 2025-02-28 |
| 2023-09-30 | $5.10M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $7.60M 10-Q · filed 2023-08-04 |
| 2022-12-31 | $6.80M 10-K · filed 2025-02-28 |
| 2022-09-30 | $7.20M 10-Q · filed 2022-11-02 |
| 2022-06-30 | $7.50M 10-Q · filed 2022-08-05 |
| 2022-03-31 | $7.90M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $8.60M 10-K · filed 2025-02-28 |
| 2021-09-30 | $8.80M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $8.50M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $8.00M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $10.90M 10-K · filed 2024-02-28 |
| 2020-09-30 | $5.90M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $6.80M 10-K · filed 2023-03-01 |
| 2020-03-31 | $6.70M 10-Q · filed 2020-05-06 |
| 2019-12-31 | $10.30M 10-Q · filed 2020-02-07 |
| 2019-09-30 | $10.70M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $13.80M 10-K · filed 2023-03-01 |
| 2019-03-31 | $14.00M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $15.70M 10-Q · filed 2019-02-06 |
| 2018-09-30 | $14.90M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $14.50M 10-K · filed 2022-02-25 |
| 2018-03-31 | $17.00M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $81.00M 10-Q · filed 2018-02-07 |
| 2017-09-30 | $67.80M 10-Q · filed 2017-11-08 |
| 2017-06-30 | $140.50M 10-K · filed 2018-08-24 |
| 2017-03-31 | $142.50M 10-Q · filed 2017-05-03 |
| 2016-12-31 | $137.10M 10-Q · filed 2017-02-08 |
| 2016-09-30 | $141.50M 10-Q · filed 2016-11-02 |
| 2016-06-30 | $10.40M 10-K · filed 2017-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |